Patents Assigned to U.S. Bioscience
  • Patent number: 5906984
    Abstract: The present invention relates to methods of stimulating he growth of hematopoietic progenitor cells. In particular, it relates to the use of thiols and related compounds in stimulating the growth of hematopoietic progenitor cells in vitro and in vivo. Furthermore, the present invention relates to methods of using these compounds for the treatment of marrow failure states and immunodeficient conditions, including but not limited to myelodysplastic syndromes and acquired immunodeficiency syndrome.
    Type: Grant
    Filed: March 24, 1998
    Date of Patent: May 25, 1999
    Assignees: Arizona Board of Regents on behalf of The University of Arizona, U.S. Bioscience
    Inventors: Robert L. Capizzi, Alan F. List
  • Patent number: 5804571
    Abstract: S-.omega.(.omega.-aminoalkylamino)alkyl dihydrogen phosphorothioates or pharmaceutically acceptable derivatives thereof are useful in protecting a patient undergoing AZT treatment for AIDS and AIDS-related complex from the harmful side effects or reactions and toxicity of the AZT.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 8, 1998
    Assignee: U.S. Bioscience
    Inventor: Philip S. Schein
  • Patent number: 4957481
    Abstract: The present invention is directed toward methods for the reduction of the severity of symptoms resulting from tumors, such as pain induced by the pressure exerted on a nerve by the tumor mass. Additionally, methods for the reduction of tumor size are also contemplated.
    Type: Grant
    Filed: July 3, 1989
    Date of Patent: September 18, 1990
    Assignee: U.S. Bioscience
    Inventor: Robert A. Gatenby